0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and India Somatostatin Market Report & Forecast 2023-2029
Published Date: November 2023
|
Report Code: QYRE-Auto-4O16000
Home | Market Reports | Science
Global and India Somatostatin Market Report Forecast 2023 2029
BUY CHAPTERS

Global and India Somatostatin Market Report & Forecast 2023-2029

Code: QYRE-Auto-4O16000
Report
November 2023
Pages:112
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

and India Somatostatin Market Size

The global Somatostatin revenue was US$ 336.6 million in 2022 and is forecast to a readjusted size of US$ 722.9 million by 2029 with a CAGR of 11.4% during the forecast period (2023-2029).

and India Somatostatin Market

and India Somatostatin Market

Somatostatin is one kind of hormone. It is widely distributed throughout the body, especially in the hypothalamus and pancreas. It also acts as an important regulator of endocrine and nervous system function by inhibiting the secretion of several other hormones such as growth hormone, insulin, and gastrin.
In India, the Somatostatin revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2023-2029).
Global Somatostatin key players include Merck (Schweiz) AG, SANOFI-AVENTIS FRANCE, Lyomark Pharma GmbH, ALFA WASSERMANN S.p.A., HYBIO, etc. Global top five manufacturers hold a share over 65%.
China is the largest market, followed by Europe and India.
This report focuses on global and India Somatostatin market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Somatostatin will continue to grow rapidly in the future.
Global Somatostatin Scope and Market Size
Somatostatin market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Somatostatin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2029.
For India market, this report focuses on the Somatostatin market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Scope of and India Somatostatin Market Report

Report Metric Details
Report Name and India Somatostatin Market
Forecasted market size in 2029 US$ 722.9 million
CAGR 11.4%
Forecasted years 2023 - 2029
Segment by Type
  • 0.25mg/pcs
  • 0.75mg/pcs
  • 3mg/pcs
Segment by Application
  • Hormonal Disorder
  • Oncology
  • Metabolic Disorder
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Merck (Schweiz) AG, SANOFI-AVENTIS FRANCE, Lyomark Pharma GmbH, ALFA WASSERMANN S.p.A., Polypeptide Laboratories, Inc, SAMARTH, UBPL, HYBIO, TianTaiShan, Yangtze River, Siyao, Shuangcheng, Hainan Zhonghe, SL PHARM, Wuhan Hualong, Qingdao Guoda, Chengdu Shengnuo, Longjin
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

What is the and India Somatostatin Market size in 2029?

Ans: The and India Somatostatin Market size in 2029 will be US$ 722.9 million.

What is the market share of major companies in and India Somatostatin Market?

Ans: Global top five manufacturers hold a share over 65%.

What is the and India Somatostatin Market share by region?

Ans: According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment.

Who are the main players in the and India Somatostatin Market report?

Ans: The main players in the and India Somatostatin Market are Merck (Schweiz) AG, SANOFI-AVENTIS FRANCE, Lyomark Pharma GmbH, ALFA WASSERMANN S.p.A., Polypeptide Laboratories, Inc, SAMARTH, UBPL, HYBIO, TianTaiShan, Yangtze River, Siyao, Shuangcheng, Hainan Zhonghe, SL PHARM, Wuhan Hualong, Qingdao Guoda, Chengdu Shengnuo, Longjin

What are the Application segmentation covered in the and India Somatostatin Market report?

Ans: The Applications covered in the and India Somatostatin Market report are Hormonal Disorder, Oncology, Metabolic Disorder, Others

What are the Type segmentation covered in the and India Somatostatin Market report?

Ans: The Types covered in the and India Somatostatin Market report are 0.25mg/pcs, 0.75mg/pcs, 3mg/pcs

1 Study Coverage
1.1 Somatostatin Product Introduction
1.2 Global Somatostatin Outlook 2018 VS 2022 VS 2029
1.2.1 Global Somatostatin Sales in US$ Million for the Year 2018-2029
1.2.2 Global Somatostatin Sales in Volume for the Year 2018-2029
1.3 India Somatostatin Outlook 2018 VS 2022 VS 2029
1.3.1 India Somatostatin Sales in US$ Million for the Year 2018-2029
1.3.2 India Somatostatin Sales in Volume for the Year 2018-2029
1.4 Somatostatin Market Size, India VS Global, 2018 VS 2022 VS 2029
1.4.1 The Market Share of India Somatostatin in Global, 2018 VS 2022 VS 2029
1.4.2 The Growth Rate of Somatostatin Market Size, India VS Global, 2018 VS 2022 VS 2029
1.5 Somatostatin Market Dynamics
1.5.1 Somatostatin Industry Trends
1.5.2 Somatostatin Market Drivers
1.5.3 Somatostatin Market Challenges
1.5.4 Somatostatin Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Somatostatin by Type
2.1 Somatostatin Market Segment by Type
2.1.1 0.25mg/pcs
2.1.2 0.75mg/pcs
2.1.3 3mg/pcs
2.2 Global Somatostatin Market Size by Type
2.2.1 Global Somatostatin Sales in Value, by Type (2018, 2022 & 2029)
2.2.2 Global Somatostatin Sales in Volume, by Type (2018, 2022 & 2029)
2.2.3 Global Somatostatin Average Selling Price (ASP) by Type (2018, 2022 & 2029)
2.3 India Somatostatin Market Size by Type
2.3.1 India Somatostatin Sales in Value, by Type (2018, 2022 & 2029)
2.3.2 India Somatostatin Sales in Volume, by Type (2018, 2022 & 2029)
2.3.3 India Somatostatin Average Selling Price (ASP) by Type (2018, 2022 & 2029)
3 Somatostatin by Application
3.1 Somatostatin Market Segment by Application
3.1.1 Hormonal Disorder
3.1.2 Oncology
3.1.3 Metabolic Disorder
3.1.4 Others
3.2 Global Somatostatin Market Size by Application
3.2.1 Global Somatostatin Sales in Value, by Application (2018, 2022 & 2029)
3.2.2 Global Somatostatin Sales in Volume, by Application (2018, 2022 & 2029)
3.3.3 Global Somatostatin Average Selling Price (ASP) by Application (2018, 2022 & 2029)
3.3 India Somatostatin Market Size by Application
3.3.1 India Somatostatin Sales in Value, by Application (2018, 2022 & 2029)
3.3.2 India Somatostatin Sales in Volume, by Application (2018, 2022 & 2029)
3.3.3 India Somatostatin Average Selling Price (ASP) by Application (2018, 2022 & 2029)
4 Global Somatostatin Competitor Landscape by Company
4.1 Global Somatostatin Market Size by Company
4.1.1 Global Key Manufacturers of Somatostatin, Ranked by Revenue (2022)
4.1.2 Global Somatostatin Revenue by Manufacturer (2018-2023)
4.1.3 Global Somatostatin Sales by Manufacturer (2018-2023)
4.1.4 Global Somatostatin Price by Manufacturer (2018-2023)
4.2 Global Somatostatin Concentration Ratio (CR)
4.2.1 Somatostatin Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Somatostatin in 2022
4.2.3 Global Somatostatin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Somatostatin, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Somatostatin, Product Offered and Application
4.5 Global Key Manufacturers of Somatostatin, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 India Somatostatin Market Size by Company
4.7.1 Key Players of Somatostatin in India, Ranked by Revenue (2022)
4.7.2 India Somatostatin Revenue by Players (2018-2023)
4.7.3 India Somatostatin Sales by Players (2018-2023)
5 Global Somatostatin Market Size by Region
5.1 Global Somatostatin Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Somatostatin Market Size in Volume by Region (2018-2029)
5.2.1 Global Somatostatin Sales in Volume by Region: 2018-2023
5.2.2 Global Somatostatin Sales in Volume Forecast by Region (2024-2029)
5.3 Global Somatostatin Market Size in Value by Region (2018-2029)
5.3.1 Global Somatostatin Sales in Value by Region: 2018-2023
5.3.2 Global Somatostatin Sales in Value by Region: 2024-2029
6 Americas
6.1 Americas Somatostatin Market Size YoY Growth 2018-2029
6.2 Americas Somatostatin Sales in Volume, by Type (2018, 2022 & 2029)
6.3 Americas Somatostatin Sales in Volume, by Application (2018, 2022 & 2029)
6.4 Americas Somatostatin Market Facts & Figures by Country (2018, 2022 & 2029)
6.4.1 Americas Somatostatin Sales in Value by Country (2018, 2022 & 2029)
6.4.2 Americas Somatostatin Sales in Volume by Country (2018, 2022 & 2029)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Somatostatin Market Size YoY Growth 2018-2029
7.2 EMEA Somatostatin Sales in Volume, by Type (2018, 2022 & 2029)
7.3 EMEA Somatostatin Sales in Volume, by Application (2018, 2022 & 2029)
7.4 EMEA Somatostatin Market Facts & Figures by Country (2018, 2022 & 2029)
7.4.1 EMEA Somatostatin Sales in Value by Country (2018, 2022 & 2029)
7.4.2 EMEA Somatostatin Sales in Volume by Country (2018, 2022 & 2029)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Somatostatin Market Size YoY Growth 2018-2029
8.2 China Somatostatin Sales in Volume, by Type (2018, 2022 & 2029)
8.3 China Somatostatin Sales in Volume, by Application (2018, 2022 & 2029)
9 APAC
9.1 APAC Somatostatin Market Size YoY Growth 2018-2029
9.2 APAC Somatostatin Sales in Volume, by Type (2018, 2022 & 2029)
9.3 APAC Somatostatin Sales in Volume, by Application (2018, 2022 & 2029)
9.4 APAC Somatostatin Market Facts & Figures by Region (2018, 2022 & 2029)
9.4.1 APAC Somatostatin Sales in Value by Region (2018, 2022 & 2029)
9.4.2 APAC Somatostatin Sales in Volume by Region (2018, 2022 & 2029)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Merck (Schweiz) AG
10.1.1 Merck (Schweiz) AG Company Information
10.1.2 Merck (Schweiz) AG Description and Business Overview
10.1.3 Merck (Schweiz) AG Somatostatin Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Merck (Schweiz) AG Somatostatin Products Offered
10.1.5 Merck (Schweiz) AG Recent Development
10.2 SANOFI-AVENTIS FRANCE
10.2.1 SANOFI-AVENTIS FRANCE Company Information
10.2.2 SANOFI-AVENTIS FRANCE Description and Business Overview
10.2.3 SANOFI-AVENTIS FRANCE Somatostatin Sales, Revenue and Gross Margin (2018-2023)
10.2.4 SANOFI-AVENTIS FRANCE Somatostatin Products Offered
10.2.5 SANOFI-AVENTIS FRANCE Recent Development
10.3 Lyomark Pharma GmbH
10.3.1 Lyomark Pharma GmbH Company Information
10.3.2 Lyomark Pharma GmbH Description and Business Overview
10.3.3 Lyomark Pharma GmbH Somatostatin Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Lyomark Pharma GmbH Somatostatin Products Offered
10.3.5 Lyomark Pharma GmbH Recent Development
10.4 ALFA WASSERMANN S.p.A.
10.4.1 ALFA WASSERMANN S.p.A. Company Information
10.4.2 ALFA WASSERMANN S.p.A. Description and Business Overview
10.4.3 ALFA WASSERMANN S.p.A. Somatostatin Sales, Revenue and Gross Margin (2018-2023)
10.4.4 ALFA WASSERMANN S.p.A. Somatostatin Products Offered
10.4.5 ALFA WASSERMANN S.p.A. Recent Development
10.5 Polypeptide Laboratories, Inc
10.5.1 Polypeptide Laboratories, Inc Company Information
10.5.2 Polypeptide Laboratories, Inc Description and Business Overview
10.5.3 Polypeptide Laboratories, Inc Somatostatin Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Polypeptide Laboratories, Inc Somatostatin Products Offered
10.5.5 Polypeptide Laboratories, Inc Recent Development
10.6 SAMARTH
10.6.1 SAMARTH Company Information
10.6.2 SAMARTH Description and Business Overview
10.6.3 SAMARTH Somatostatin Sales, Revenue and Gross Margin (2018-2023)
10.6.4 SAMARTH Somatostatin Products Offered
10.6.5 SAMARTH Recent Development
10.7 UBPL
10.7.1 UBPL Company Information
10.7.2 UBPL Description and Business Overview
10.7.3 UBPL Somatostatin Sales, Revenue and Gross Margin (2018-2023)
10.7.4 UBPL Somatostatin Products Offered
10.7.5 UBPL Recent Development
10.8 HYBIO
10.8.1 HYBIO Company Information
10.8.2 HYBIO Description and Business Overview
10.8.3 HYBIO Somatostatin Sales, Revenue and Gross Margin (2018-2023)
10.8.4 HYBIO Somatostatin Products Offered
10.8.5 HYBIO Recent Development
10.9 TianTaiShan
10.9.1 TianTaiShan Company Information
10.9.2 TianTaiShan Description and Business Overview
10.9.3 TianTaiShan Somatostatin Sales, Revenue and Gross Margin (2018-2023)
10.9.4 TianTaiShan Somatostatin Products Offered
10.9.5 TianTaiShan Recent Development
10.10 Yangtze River
10.10.1 Yangtze River Company Information
10.10.2 Yangtze River Description and Business Overview
10.10.3 Yangtze River Somatostatin Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Yangtze River Somatostatin Products Offered
10.10.5 Yangtze River Recent Development
10.11 Siyao
10.11.1 Siyao Company Information
10.11.2 Siyao Description and Business Overview
10.11.3 Siyao Somatostatin Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Siyao Somatostatin Products Offered
10.11.5 Siyao Recent Development
10.12 Shuangcheng
10.12.1 Shuangcheng Company Information
10.12.2 Shuangcheng Description and Business Overview
10.12.3 Shuangcheng Somatostatin Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Shuangcheng Somatostatin Products Offered
10.12.5 Shuangcheng Recent Development
10.13 Hainan Zhonghe
10.13.1 Hainan Zhonghe Company Information
10.13.2 Hainan Zhonghe Description and Business Overview
10.13.3 Hainan Zhonghe Somatostatin Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Hainan Zhonghe Somatostatin Products Offered
10.13.5 Hainan Zhonghe Recent Development
10.14 SL PHARM
10.14.1 SL PHARM Company Information
10.14.2 SL PHARM Description and Business Overview
10.14.3 SL PHARM Somatostatin Sales, Revenue and Gross Margin (2018-2023)
10.14.4 SL PHARM Somatostatin Products Offered
10.14.5 SL PHARM Recent Development
10.15 Wuhan Hualong
10.15.1 Wuhan Hualong Company Information
10.15.2 Wuhan Hualong Description and Business Overview
10.15.3 Wuhan Hualong Somatostatin Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Wuhan Hualong Somatostatin Products Offered
10.15.5 Wuhan Hualong Recent Development
10.16 Qingdao Guoda
10.16.1 Qingdao Guoda Company Information
10.16.2 Qingdao Guoda Description and Business Overview
10.16.3 Qingdao Guoda Somatostatin Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Qingdao Guoda Somatostatin Products Offered
10.16.5 Qingdao Guoda Recent Development
10.17 Chengdu Shengnuo
10.17.1 Chengdu Shengnuo Company Information
10.17.2 Chengdu Shengnuo Description and Business Overview
10.17.3 Chengdu Shengnuo Somatostatin Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Chengdu Shengnuo Somatostatin Products Offered
10.17.5 Chengdu Shengnuo Recent Development
10.18 Longjin
10.18.1 Longjin Company Information
10.18.2 Longjin Description and Business Overview
10.18.3 Longjin Somatostatin Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Longjin Somatostatin Products Offered
10.18.5 Longjin Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Somatostatin Industry Chain Analysis
11.2 Somatostatin Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Somatostatin Production Mode & Process
11.4 Somatostatin Sales and Marketing
11.4.1 Somatostatin Sales Channels
11.4.2 Somatostatin Distributors
11.5 Somatostatin Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
    Table 1. Somatostatin CAGR in Value, India VS Global, 2018 VS 2022 VS 2029
    Table 2. Somatostatin Market Trends
    Table 3. Somatostatin Market Drivers
    Table 4. Somatostatin Market Challenges
    Table 5. Somatostatin Market Restraints
    Table 6. Global Somatostatin Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 7. India Somatostatin Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 8. Global Somatostatin Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 9. India Somatostatin Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 10. Global Key Manufacturers of Somatostatin, Ranked by Revenue (2022) & (US$ Million)
    Table 11. Global Somatostatin Revenue by Manufacturer, (US$ Million), 2018-2023
    Table 12. Global Somatostatin Revenue Share by Manufacturer, 2018-2023
    Table 13. Global Somatostatin Sales by Manufacturer, (K Pcs), 2018-2023
    Table 14. Global Somatostatin Sales Share by Manufacturer, 2018-2023
    Table 15. Global Somatostatin Price by Manufacturer (2018-2023) & (USD/Pcs)
    Table 16. Global Somatostatin Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Somatostatin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Somatostatin as of 2022)
    Table 18. Global Key Manufacturers of Somatostatin, Manufacturing Base Distribution and Headquarters
    Table 19. Global Key Manufacturers of Somatostatin, Product Offered and Application
    Table 20. Global Key Manufacturers of Somatostatin, Date of Enter into This Industry
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Key Players of Somatostatin in India, Ranked by Revenue (2022) & (US$ million)
    Table 23. India Somatostatin Revenue by Players, (US$ Million), (2018-2023)
    Table 24. India Somatostatin Revenue Share by Players, (2018-2023)
    Table 25. India Somatostatin Sales by Players, (K Pcs), (2018-2023)
    Table 26. India Somatostatin Sales Share by Players, (2018-2023)
    Table 27. Global Somatostatin Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 28. Global Somatostatin Sales in Volume by Region (2018-2023) & (K Pcs)
    Table 29. Global Somatostatin Sales in Volume Forecast by Region (2024-2029) & (K Pcs)
    Table 30. Global Somatostatin Sales in Value by Region (2018-2023) & (US$ Million)
    Table 31. Global Somatostatin Sales in Value Forecast by Region (2024-2029) & (US$ Million)
    Table 32. Americas Somatostatin Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 33. Americas Somatostatin Sales in Value by Country (2018-2023) & (US$ Million)
    Table 34. Americas Somatostatin Sales in Value by Country (2024-2029) & (US$ Million)
    Table 35. Americas Somatostatin Sales in Volume by Country (2018-2023) & (K Pcs)
    Table 36. Americas Somatostatin Sales in Volume by Country (2024-2029) & (K Pcs)
    Table 37. EMEA Somatostatin Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 38. EMEA Somatostatin Sales in Value by Country (2018-2023) & (US$ Million)
    Table 39. EMEA Somatostatin Sales in Value by Country (2024-2029) & (US$ Million)
    Table 40. EMEA Somatostatin Sales in Volume by Country (2018-2023) & (K Pcs)
    Table 41. EMEA Somatostatin Sales in Volume by Country (2024-2029) & (K Pcs)
    Table 42. APAC Somatostatin Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 43. APAC Somatostatin Sales in Value by Country (2018-2023) & (US$ Million)
    Table 44. APAC Somatostatin Sales in Value by Country (2024-2029) & (US$ Million)
    Table 45. APAC Somatostatin Sales in Volume by Country (2018-2023) & (K Pcs)
    Table 46. APAC Somatostatin Sales in Volume by Country (2024-2029) & (K Pcs)
    Table 47. Merck (Schweiz) AG Company Information
    Table 48. Merck (Schweiz) AG Description and Business Overview
    Table 49. Merck (Schweiz) AG Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 50. Merck (Schweiz) AG Somatostatin Product
    Table 51. Merck (Schweiz) AG Recent Development
    Table 52. SANOFI-AVENTIS FRANCE Company Information
    Table 53. SANOFI-AVENTIS FRANCE Description and Business Overview
    Table 54. SANOFI-AVENTIS FRANCE Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 55. SANOFI-AVENTIS FRANCE Somatostatin Product
    Table 56. SANOFI-AVENTIS FRANCE Recent Development
    Table 57. Lyomark Pharma GmbH Company Information
    Table 58. Lyomark Pharma GmbH Description and Business Overview
    Table 59. Lyomark Pharma GmbH Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 60. Lyomark Pharma GmbH Somatostatin Product
    Table 61. Lyomark Pharma GmbH Recent Development
    Table 62. ALFA WASSERMANN S.p.A. Company Information
    Table 63. ALFA WASSERMANN S.p.A. Description and Business Overview
    Table 64. ALFA WASSERMANN S.p.A. Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 65. ALFA WASSERMANN S.p.A. Somatostatin Product
    Table 66. ALFA WASSERMANN S.p.A. Recent Development
    Table 67. Polypeptide Laboratories, Inc Company Information
    Table 68. Polypeptide Laboratories, Inc Description and Business Overview
    Table 69. Polypeptide Laboratories, Inc Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 70. Polypeptide Laboratories, Inc Somatostatin Product
    Table 71. Polypeptide Laboratories, Inc Recent Development
    Table 72. SAMARTH Company Information
    Table 73. SAMARTH Description and Business Overview
    Table 74. SAMARTH Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 75. SAMARTH Somatostatin Product
    Table 76. SAMARTH Recent Development
    Table 77. UBPL Company Information
    Table 78. UBPL Description and Business Overview
    Table 79. UBPL Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 80. UBPL Somatostatin Product
    Table 81. UBPL Recent Development
    Table 82. HYBIO Company Information
    Table 83. HYBIO Description and Business Overview
    Table 84. HYBIO Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 85. HYBIO Somatostatin Product
    Table 86. HYBIO Recent Development
    Table 87. TianTaiShan Company Information
    Table 88. TianTaiShan Description and Business Overview
    Table 89. TianTaiShan Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 90. TianTaiShan Somatostatin Product
    Table 91. TianTaiShan Recent Development
    Table 92. Yangtze River Company Information
    Table 93. Yangtze River Description and Business Overview
    Table 94. Yangtze River Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 95. Yangtze River Somatostatin Product
    Table 96. Yangtze River Recent Development
    Table 97. Siyao Company Information
    Table 98. Siyao Description and Business Overview
    Table 99. Siyao Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 100. Siyao Somatostatin Product
    Table 101. Siyao Recent Development
    Table 102. Shuangcheng Company Information
    Table 103. Shuangcheng Description and Business Overview
    Table 104. Shuangcheng Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 105. Shuangcheng Somatostatin Product
    Table 106. Shuangcheng Recent Development
    Table 107. Hainan Zhonghe Company Information
    Table 108. Hainan Zhonghe Description and Business Overview
    Table 109. Hainan Zhonghe Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 110. Hainan Zhonghe Somatostatin Product
    Table 111. Hainan Zhonghe Recent Development
    Table 112. SL PHARM Company Information
    Table 113. SL PHARM Description and Business Overview
    Table 114. SL PHARM Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 115. SL PHARM Somatostatin Product
    Table 116. SL PHARM Recent Development
    Table 117. Wuhan Hualong Company Information
    Table 118. Wuhan Hualong Description and Business Overview
    Table 119. Wuhan Hualong Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 120. Wuhan Hualong Somatostatin Product
    Table 121. Wuhan Hualong Recent Development
    Table 122. Qingdao Guoda Company Information
    Table 123. Qingdao Guoda Description and Business Overview
    Table 124. Qingdao Guoda Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 125. Qingdao Guoda Somatostatin Product
    Table 126. Qingdao Guoda Recent Development
    Table 127. Chengdu Shengnuo Company Information
    Table 128. Chengdu Shengnuo Description and Business Overview
    Table 129. Chengdu Shengnuo Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 130. Chengdu Shengnuo Somatostatin Product
    Table 131. Chengdu Shengnuo Recent Development
    Table 132. Longjin Company Information
    Table 133. Longjin Description and Business Overview
    Table 134. Longjin Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 135. Longjin Somatostatin Product
    Table 136. Longjin Recent Development
    Table 137. Key Raw Materials Lists
    Table 138. Raw Materials Key Suppliers Lists
    Table 139. Somatostatin Customers List
    Table 140. Somatostatin Distributors List
    Table 141. Research Programs/Design for This Report
    Table 142. Key Data Information from Secondary Sources
    Table 143. Key Data Information from Primary Sources
List of Figures
    Figure 1. Somatostatin Product Picture
    Figure 2. Global Somatostatin Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Somatostatin Market Size 2018-2029 (US$ Million)
    Figure 4. Global Somatostatin Sales 2018-2029 (K Pcs)
    Figure 5. India Somatostatin Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 6. India Somatostatin Market Size 2018-2029 (US$ Million)
    Figure 7. India Somatostatin Sales 2018-2029 (K Pcs)
    Figure 8. India Somatostatin Market Share in Global, in Value (US$ Million) 2018-2029
    Figure 9. India Somatostatin Market Share in Global, in Volume (K Pcs) 2018-2029
    Figure 10. Somatostatin Report Years Considered
    Figure 11. Product Picture of 0.25mg/pcs
    Figure 12. Product Picture of 0.75mg/pcs
    Figure 13. Product Picture of 3mg/pcs
    Figure 14. Global Somatostatin Market Share by Type in 2022 & 2029
    Figure 15. Global Somatostatin Sales in Value by Type (2018-2029) & (US$ Million)
    Figure 16. Global Somatostatin Sales Market Share in Value by Type (2018-2029)
    Figure 17. Global Somatostatin Sales by Type (2018-2029) & (K Pcs)
    Figure 18. Global Somatostatin Sales Market Share in Volume by Type (2018-2029)
    Figure 19. Global Somatostatin Price by Type (2018-2029) & (USD/Pcs)
    Figure 20. India Somatostatin Market Share by Type in 2022 & 2029
    Figure 21. India Somatostatin Sales in Value by Type (2018-2029) & (US$ Million)
    Figure 22. India Somatostatin Sales Market Share in Value by Type (2018-2029)
    Figure 23. India Somatostatin Sales by Type (2018-2029) & (K Pcs)
    Figure 24. India Somatostatin Sales Market Share in Volume by Type (2018-2029)
    Figure 25. India Somatostatin Price by Type (2018-2029) & (USD/Pcs)
    Figure 26. Product Picture of Hormonal Disorder
    Figure 27. Product Picture of Oncology
    Figure 28. Product Picture of Metabolic Disorder
    Figure 29. Product Picture of Others
    Figure 30. Global Somatostatin Market Share by Application in 2022 & 2029
    Figure 31. Global Somatostatin Sales in Value by Application (2018-2029) & (US$ Million)
    Figure 32. Global Somatostatin Sales Market Share in Value by Application (2018-2029)
    Figure 33. Global Somatostatin Sales by Application (2018-2029) & (K Pcs)
    Figure 34. Global Somatostatin Sales Market Share in Volume by Application (2018-2029)
    Figure 35. Global Somatostatin Price by Application (2018-2029) & (USD/Pcs)
    Figure 36. India Somatostatin Market Share by Application in 2022 & 2029
    Figure 37. India Somatostatin Sales in Value by Application (2018-2029) & (US$ Million)
    Figure 38. India Somatostatin Sales Market Share in Value by Application (2018-2029)
    Figure 39. India Somatostatin Sales by Application (2018-2029) & (K Pcs)
    Figure 40. India Somatostatin Sales Market Share in Volume by Application (2018-2029)
    Figure 41. India Somatostatin Price by Application (2018-2029) & (USD/Pcs)
    Figure 42. Americas Somatostatin Sales in Volume Growth Rate 2018-2029 (K Pcs)
    Figure 43. Americas Somatostatin Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 44. Americas Somatostatin Sales by Type (2018-2029) & (K Pcs)
    Figure 45. Americas Somatostatin Sales Market Share in Volume by Type (2018-2029)
    Figure 46. Americas Somatostatin Sales by Application (2018-2029) & (K Pcs)
    Figure 47. Americas Somatostatin Sales Market Share in Volume by Application (2018-2029)
    Figure 48. United States Somatostatin Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 49. Canada Somatostatin Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 50. Mexico Somatostatin Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 51. Brazil Somatostatin Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 52. EMEA Somatostatin Sales in Volume Growth Rate 2018-2029 (K Pcs)
    Figure 53. EMEA Somatostatin Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 54. EMEA Somatostatin Sales by Type (2018-2029) & (K Pcs)
    Figure 55. EMEA Somatostatin Sales Market Share in Volume by Type (2018-2029)
    Figure 56. EMEA Somatostatin Sales by Application (2018-2029) & (K Pcs)
    Figure 57. EMEA Somatostatin Sales Market Share in Volume by Application (2018-2029)
    Figure 58. Europe Somatostatin Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 59. Middle East Somatostatin Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 60. Africa Somatostatin Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 61. China Somatostatin Sales in Volume Growth Rate 2018-2029 (K Pcs)
    Figure 62. China Somatostatin Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 63. China Somatostatin Sales by Type (2018-2029) & (K Pcs)
    Figure 64. China Somatostatin Sales Market Share in Volume by Type (2018-2029)
    Figure 65. China Somatostatin Sales by Application (2018-2029) & (K Pcs)
    Figure 66. China Somatostatin Sales Market Share in Volume by Application (2018-2029)
    Figure 67. APAC Somatostatin Sales in Volume Growth Rate 2018-2029 (K Pcs)
    Figure 68. APAC Somatostatin Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 69. APAC Somatostatin Sales by Type (2018-2029) & (K Pcs)
    Figure 70. APAC Somatostatin Sales Market Share in Volume by Type (2018-2029)
    Figure 71. APAC Somatostatin Sales by Application (2018-2029) & (K Pcs)
    Figure 72. APAC Somatostatin Sales Market Share in Volume by Application (2018-2029)
    Figure 73. Japan Somatostatin Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 74. South Korea Somatostatin Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 75. China Taiwan Somatostatin Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 76. Southeast Asia Somatostatin Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 77. India Somatostatin Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 78. Somatostatin Value Chain
    Figure 79. Somatostatin Production Process
    Figure 80. Channels of Distribution
    Figure 81. Distributors Profiles
    Figure 82. Bottom-up and Top-down Approaches for This Report
    Figure 83. Data Triangulation
    Figure 84. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4350

This license allows only one user to access the PDF.
Electronic (PDF)

$6525

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$8700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS